2014, Number S1
<< Back Next >>
Rev Mex Anest 2014; 37 (S1)
Summary triple scheme: dexmedetomidine-propofol-remifentanil
Pastor JM
Language: Spanish
References: 8
Page: 190-191
PDF size: 133.45 Kb.
Text Extraction
REFERENCES
García BA, Rodriguez L, Salazar PFA, Venegas SA. Uso de dexmedetomidina en anestesia total intravenosa (TIVA). Rev Colomb Anestesiol. 2011;39:514-526.
Carollo DS, Nossaman BD, Ramadhyani U. Dexmedetomidine: a review of clinical applications. Curr Opin. 2008;21:457-451.
Ishii H, Kohno T, Yamakura T, Ikoma M, Baba H. Action of dexmedetomidine on the substantia gelatinosa neurons of the rat spinal cord. Eur J Neurosci. 2008;27:3182.
Hsu YW, Cortinez LI, Robertson KM, Keifer JC, Sum-Ping ST, Moretti EW, et al. Dexmedetomidine pharmacodynamics: part I: crossover comparison of the respiratory effects of dexmedetomidine and remifentanyl in healthy volunteers. Anesthesiology. 2004;101:1066-1076.
El-Gohary MM, Arafa AS. Dexmedetomidine as a hypotensive agent: efficacy and hemodynamic response during spinal surgery for idiopathic scoliosis in adolescents. Egyp J Anaesth. 2010;26:305-311.
Ayoglu H, Yapakci O, Ugur MB, Uzun L, Altunkaya H, Ozer Y, et al. Effectiveness of dexmedetomidine in reducing bleeding during septoplasty and tympanoplasty operations. J Clin Anesth. 2008;20:437-441.
Bekker A, Sturaitis MK. Dexmedetomidine for neurological surgery. Neurosurgery. 2005;57:1-10.
Boyd BC, Sutter SJ. Dexmedetomidine sedation for awake fiberoptic intubation of patients with difficult airways due to severe odontogenic cervicofacial infections. J Oral Maxillofac Surg. 2011;69:1608-1612.